Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Biotricity, Inc.
  6. Summary
    BTCY   US09074H1041

BIOTRICITY, INC.

(BTCY)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
3(c) 3.11(c) 3.11(c) 3.475(c) 4.24(c) Last
104 278 129 681 199 968 2 205 571 2 194 420 Volume
-0.33% +3.67% 0.00% +11.74% +22.01% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 8,84 M - -
Net income 2022 -29,5 M - -
Net Debt 2022 - - -
P/E ratio 2022 -6,14x
Yield 2022 -
Sales 2023 22,5 M - -
Net income 2023 -25,8 M - -
Net Debt 2023 - - -
P/E ratio 2023 -9,64x
Yield 2023 -
Capitalization 202 M 202 M -
Capi. / Sales 2022 22,8x
Capi. / Sales 2023 8,96x
Nbr of Employees 44
Free-Float 91,1%
More Financials
Company
Biotricity Inc is a Canada-based medical technology company. The Company delivers remote biometric monitoring solutions, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. It offers bioflux, an Electrocardiogram (ECG) monitoring system that enables physicians to diagnose cardiovascular diseases or coronary heart diseases, acts as an ambulatory monitor that detects... 
More about the company
All news about BIOTRICITY, INC.
09/13BIOTRICITY INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/10BIOTRICITY INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/31BIOTRICITY INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fi..
AQ
08/17BIOTRICITY INC. : Results of Operations and Financial Condition, Financial Statements and ..
AQ
08/17Biotricity, Inc. Provides Revenue Guidance for the Fiscal 2022 and Fiscal 2023
CI
08/17BIOTRICITY : Management's Discussion and Analysis of Financial Condition and Results of Op..
AQ
08/17Biotricity, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2021
CI
08/17BIOTRICITY : Management's Discussion and Analysis of Financial Condition and Results of Op..
AQ
07/08BIOTRICITY INC. : Results of Operations and Financial Condition, Financial Statements and ..
AQ
07/08Biotricity, Inc. Provides Preliminary Earnings Guidance for the First Quarter Ended Jun..
CI
06/22Biotricity, Inc. Reports Earnings Results for the Full Year Ended March 31, 2021
CI
06/22BIOTRICITY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OP..
AQ
06/17BIOTRICITY INC. : Results of Operations and Financial Condition, Financial Statements and ..
AQ
06/17Biotricity, Inc. Announces Earnings Guidance for the Fiscal 2022
CI
04/27BIOTRICITY : Change in Directors or Principal Officers (form 8-K/A)
AQ
More news
News in other languages on BIOTRICITY, INC.

- No features available -

More news
Chart BIOTRICITY, INC.
Duration : Period :
Biotricity, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 4,24 $
Average target price 6,50 $
Spread / Average Target 53,3%
EPS Revisions
Managers and Directors
Waqaas Al-Siddiq Chairman, President & Chief Executive Officer
John Ayanoglou Chief Financial Officer
Spencer LaDow Vice President-Engineering
Norman Murray Betts Independent Director
David A. Rosa Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BIOTRICITY, INC.474.33%202
THERMO FISHER SCIENTIFIC30.62%240 757
DANAHER CORPORATION39.88%223 934
INTUITIVE SURGICAL, INC.25.24%122 004
SIEMENS HEALTHINEERS AG40.64%77 031
EDWARDS LIFESCIENCES CORPORATION26.87%72 674